Saturday 17 October 2026
Export BFLY’s income statement to Excel — free account
Butterfly Network, Inc.
BFLY Healthcare Medical Devices
Butterfly Network, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $97.6 million, up 19.0% from fiscal 2024. In the quarter to June 2026, revenue grew 39.5%, EPS grew 16.7% and free cash flow fell 113.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
7.25
0.60
−7.64%
Follow BFLY
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
19.68 | 10.07 | 9.62 | 5.50 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(135.65) | (74.59) | 103.98 | (168.52) | |
P/B ratio |
11.65 | 5.42 | 4.79 | 2.39 | |
Price to Tangible BV |
12.09 | 5.63 | 4.98 | 2.48 | |
EV/Sales |
19.05 | 9.25 | 8.63 | 4.48 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(88.93) | (63.84) | (66.34) | (15.94) | |
EV/FCF |
(76.18) | (50.49) | (52.50) | (14.39) | |
Quick Ratio |
2.72 | 2.74 | 2.72 | 3.35 | |
Current Ratio |
4.06 | 4.02 | 3.83 | 4.80 | |
Net Debt/EBITDA |
10.38 | 11.44 | 10.06 | 4.34 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.38 | 0.34 | 0.35 | 0.32 | |
Operating CF/Net income |
1.26 | 1.10 | (0.59) | 0.09 | |
Capex/Depreciation |
(0.59) | (0.52) | (0.62) | (0.54) | |
Interest Coverage |
(48.45) | (49.72) | (42.85) | (91.26) | |
Research and Development Expense of Revenue |
32.33% | 35.95% | 29.58% | 40.50% | |
Selling, General and Administrative Expense of Revenue |
69.98% | 83.81% | 73.90% | 92.68% | |
Intangible Assets out of Total Assets |
0.02 | 0.03 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
21.58% | 20.89% | 20.19% | 22.92% | |
Graham Net Nets |
0.07 | 0.14 | 0.16 | 0.32 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.44%) | (7.43%) | (8.16%) | (17.10%) | |
Free Cash Flow Yield |
(1.27%) | (1.82%) | (1.71%) | (5.66%) | |
Revenue per Share |
0.12 | 0.10 | 0.13 | 0.09 | |
Operating CF per Share |
(0.06) | (0.05) | 0.04 | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.07) | (0.06) | 0.03 | (0.02) | |
Cash per Share |
0.48 | 0.54 | 0.61 | 0.57 | |
Shareholders Equity per Share |
0.72 | 0.75 | 0.79 | 0.81 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.72 | 0.75 | 0.79 | 0.81 | |
Free Cash Flow |
(17.24) | (14.84) | 7.95 | (3.90) | |
Working Capital |
179.34 | 180.21 | 183.99 | 191.06 | |
Capital Expenditures |
(0.97) | (0.95) | (1.08) | (1.02) | |
Net Current Asset Value |
144.35 | 145.09 | 148.55 | 155.22 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.04 | 0.03 | 0.05 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
29.54 | 22.55 | 23.77 | 22.52 | |
Average Payables |
3.42 | 2.55 | 4.85 | 14.77 | |
Average Inventory |
63.73 | 64.31 | 66.09 | 67.75 | |
Average Assets |
298.14 | 302.17 | 276.31 | 277.64 | |
Average Common Equity |
211.10 | 215.46 | 182.41 | 192.83 |
Columns are period end dates